Crossref

1. Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis

- Manit Srisurapanont

- Surinporn Likhitsathian

- Sirijit Suttajit

- Narong Maneeton

- Benchalak Maneeton

- Awirut Oon‐arom

- Chawisa Suradom

2. Chronic methamphetamine self-administration dysregulates 5-HT2A and mGlu2 receptor expression in the rat prefrontal and perirhinal cortex: Comparison to chronic phencyclidine and MK-801

- Peter U. Hámor

- Jana Šírová

- Tomáš Páleníček

- Magdalena Zaniewska

- Věra Bubeníková-Valešová

- Marek Schwendt

3. Methamphetamine Dependence and Technology-Based Interventions in Iran

- Mohammad Effatpanah

- Afsaneh Moradi

4. Initiation of Antipsychotic Treatment for Amphetamine Induced Psychosis and Its Impact on Length of Stay

- Claire Herbst

- Megan O’Connell

- Brittany L. Melton

- Karen E. Moeller

5. Treatment of amphetamine abuse/use disorder: a systematic review of a recent health concern

- Mansour Khoramizadeh

- Mohammad Effatpanah

- Alireza Mostaghimi

- Mehdi Rezaei

- Alireza Mahjoub

- Sara Shishehgar

6. Methamphetamine‐associated psychosis: Clinical presentation, biological basis, and treatment options

- Mathew Chiang

- Domenico Lombardi

- Jiang Du

- Ursula Makrum

- Rangsun Sitthichai

- Amy Harrington

- Nawras Shukair

- Min Zhao

- Xiaoduo Fan

7. Antipsychotics for Amphetamine Psychosis. A Systematic Review

- Dimy Fluyau

- Paroma Mitra

- Kervens Lorthe

8. Pharmacotherapy treatment of stimulant use disorder

- Mei T. Liu

9. Into a Deeper Understanding of CYP2D6’s Role in Risperidone Monotherapy and the Potential Side Effects in Schizophrenia Spectrum Disorders

- Mariana Bondrescu

- Liana Dehelean

- Simona Farcas

- Patricia Alexandra Dragan

- Carla Andreea Podaru

- Laura Popa

- Nicoleta Andreescu